1. Home
  2. VSEC vs BLTE Comparison

VSEC vs BLTE Comparison

Compare VSEC & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSEC
  • BLTE
  • Stock Information
  • Founded
  • VSEC 1959
  • BLTE 2018
  • Country
  • VSEC United States
  • BLTE United States
  • Employees
  • VSEC N/A
  • BLTE N/A
  • Industry
  • VSEC Military/Government/Technical
  • BLTE Biotechnology: Pharmaceutical Preparations
  • Sector
  • VSEC Consumer Discretionary
  • BLTE Health Care
  • Exchange
  • VSEC Nasdaq
  • BLTE Nasdaq
  • Market Cap
  • VSEC 2.1B
  • BLTE 2.1B
  • IPO Year
  • VSEC N/A
  • BLTE 2022
  • Fundamental
  • Price
  • VSEC $130.09
  • BLTE $64.87
  • Analyst Decision
  • VSEC Strong Buy
  • BLTE Strong Buy
  • Analyst Count
  • VSEC 6
  • BLTE 4
  • Target Price
  • VSEC $125.17
  • BLTE $96.67
  • AVG Volume (30 Days)
  • VSEC 282.9K
  • BLTE 30.4K
  • Earning Date
  • VSEC 05-06-2025
  • BLTE 05-13-2025
  • Dividend Yield
  • VSEC 0.31%
  • BLTE N/A
  • EPS Growth
  • VSEC N/A
  • BLTE N/A
  • EPS
  • VSEC 0.67
  • BLTE N/A
  • Revenue
  • VSEC $1,173,794,000.00
  • BLTE N/A
  • Revenue This Year
  • VSEC $2.95
  • BLTE N/A
  • Revenue Next Year
  • VSEC $11.60
  • BLTE N/A
  • P/E Ratio
  • VSEC $55.67
  • BLTE N/A
  • Revenue Growth
  • VSEC 40.70
  • BLTE N/A
  • 52 Week Low
  • VSEC $73.36
  • BLTE $43.70
  • 52 Week High
  • VSEC $139.51
  • BLTE $86.53
  • Technical
  • Relative Strength Index (RSI)
  • VSEC 58.05
  • BLTE 55.26
  • Support Level
  • VSEC $127.01
  • BLTE $60.23
  • Resistance Level
  • VSEC $131.01
  • BLTE $66.10
  • Average True Range (ATR)
  • VSEC 4.04
  • BLTE 2.80
  • MACD
  • VSEC -0.58
  • BLTE 0.02
  • Stochastic Oscillator
  • VSEC 37.24
  • BLTE 34.37

About VSEC VSE Corporation

VSE Corp is a diversified aftermarket products and services company providing repair services, parts distribution, logistics, supply chain management and consulting services for land, sea and air transportation assets to commercial and government markets. Its operations include supply chain management solutions, parts supply and distribution, and maintenance, repair and overhaul (MRO) services for vehicle fleet, aviation, maritime and other customers. Its reportable segments are; Aviation and Fleet. Majority of the revenue for the company is generated from the Aviation segment which is a provider of aftermarket parts distribution and MRO services for components and engine accessories supporting commercial, business and general aviation operators.

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

Share on Social Networks: